ProCE Banner Activity

DolPHIN-2 Final Results: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Started in Late Pregnancy Through 72 Wks Postpartum

Slideset Download
Conference Coverage
Superior virologic efficacy observed with DTG-based regimen vs EFV-based regimen throughout pregnancy and through the breastfeeding period: final results of the DolPHIN-2 study.

Released: March 10, 2021

Expiration: March 09, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare